SCHEDULE 13G Filed 2026-06-05 Event — SEC 0001104659-26-071020 →

ADAR1 Capital Management, LLC → InMed Pharmaceuticals, Inc. INM

Stake: — Shares: — CUSIP: 457637700 Class: Common Shares, no par value

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

7 transactions

7 buys · 0 sales · 0 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest · settle 2026-07-15

DTC 2.63

119,223 shares short · -15.9% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-07-16	Vivo Opportunity, LLC	10%+ owner	Buy	19	$1.55	$29
2026-07-16	Vivo Opportunity, LLC	10%+ owner	Buy	2	$1.55	$3
2026-07-15	Vivo Opportunity, LLC	10%+ owner	Buy	13,761	$1.55	$21K
2026-07-15	Vivo Opportunity, LLC	10%+ owner	Buy	1,389	$1.55	$2K
2026-07-15	ADAR1 Capital Management, LLC	10%+ owner	Buy	1,000	$1.55	$2K
2026-07-14	Vivo Opportunity, LLC	10%+ owner	Buy	4,882	$1.55	$8K
2026-07-14	Vivo Opportunity, LLC	10%+ owner	Buy	493	$1.55	$764

Other 13D/G Filings on InMed Pharmaceuticals, Inc.

Filed	Form	Filer	Stake	Shares
2026-06-10	SCHEDULE 13D	Vivo Opportunity Fund Holdings, L.P.	21.70%	718,444	view →
2026-05-27	SCHEDULE 13G	Squadron Capital Management LLC	—	—	view →

Other Filings by ADAR1 Capital Management, LLC

Filed	Form	Issuer	Stake	Shares
2026-06-05	SCHEDULE 13G	Rallybio Corporation RLYB	—	—	view →
2025-04-28	SCHEDULE	Keros Therapeutics, Inc. KROS	13.29%	5,390,964	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →